Vilmundur Gudnason Selected Research

Vilmundur Gudnason Research Topics

Disease

32	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 10/2005
27	Coronary Disease (Coronary Heart Disease) 10/2023 - 04/2004
25	Type 2 Diabetes Mellitus (MODY) 01/2023 - 03/2005
18	Inflammation (Inflammations) 01/2019 - 06/2003
17	Atherosclerosis 07/2023 - 10/2003
14	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 04/2012
14	Obesity 10/2023 - 11/2010
14	Myocardial Infarction 07/2021 - 04/2002
12	Hypertension (High Blood Pressure) 04/2024 - 09/2005
12	Stroke (Strokes) 01/2024 - 10/2003
11	Heart Failure 11/2023 - 03/2005
9	Dementia (Dementias) 02/2024 - 04/2012
9	Atrial Fibrillation 01/2022 - 02/2010
8	Chronic Renal Insufficiency 12/2023 - 09/2005
8	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 08/2010
8	Macular Degeneration (Age-Related Maculopathy) 01/2019 - 05/2011
7	Genetic Risk Score 04/2024 - 11/2014
7	Insulin Resistance 07/2019 - 06/2011
6	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 08/2013
6	Diabetes Mellitus 01/2019 - 03/2008
6	Osteoarthritis 01/2019 - 01/2011
5	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2013
5	Neoplasms (Cancer) 01/2021 - 02/2016
4	Non-alcoholic Fatty Liver Disease 12/2023 - 03/2011
4	Hip Fractures (Intertrochanteric Fractures) 01/2022 - 01/2014
4	Fibrosis (Cirrhosis) 01/2021 - 03/2011
4	Gout 10/2019 - 12/2010
4	Geographic Atrophy 01/2019 - 05/2011
4	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019 - 12/2010
3	Cognitive Dysfunction 02/2024 - 04/2012
3	Ischemic Stroke 01/2024 - 10/2003
3	COVID-19 04/2021 - 06/2020
3	Glucose Intolerance 01/2021 - 03/2005
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 01/2018
3	Brain Infarction 09/2015 - 05/2009
3	Vascular Diseases (Vascular Disease) 09/2011 - 12/2009
2	Cerebral Small Vessel Diseases 08/2023 - 08/2023
2	Disease Progression 01/2023 - 11/2014
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2022 - 12/2005
2	Migraine Disorders (Migraine) 01/2022 - 08/2011
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2021
2	Heart Diseases (Heart Disease) 12/2021 - 10/2005
2	Cysts 01/2021 - 10/2016
2	Bronchiectasis 01/2021 - 08/2020
2	Atrophy 01/2021 - 01/2014
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 10/2020 - 02/2003
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2020 - 11/2014
2	Kidney Diseases (Kidney Disease) 11/2019 - 06/2009

Drug/Important Bio-Agent (IBA)

27	Biomarkers (Surrogate Marker)IBA 02/2024 - 07/2004
27	LipidsIBA 01/2023 - 04/2002
26	Proteins (Proteins, Gene)FDA Link 01/2024 - 03/2004
18	CholesterolIBA 10/2023 - 04/2002
17	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 08/2002
15	Triglycerides (Triacylglycerol)IBA 01/2023 - 04/2002
13	C-Reactive ProteinIBA 11/2018 - 04/2004
12	CreatinineIBA 12/2023 - 09/2005
11	Apolipoproteins E (ApoE)IBA 01/2024 - 01/2013
10	Insulin (Novolin)FDA Link 11/2022 - 06/2007
9	CalciumIBA 01/2023 - 12/2010
9	LDL CholesterolIBA 12/2021 - 08/2010
8	HDL CholesterolIBA 10/2023 - 08/2010
7	pro-brain natriuretic peptide (1-76)IBA 07/2021 - 12/2009
7	oxidized low density lipoproteinIBA 10/2020 - 02/2014
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 05/2006
6	ApolipoproteinsIBA 10/2023 - 06/2012
6	Uric Acid (Urate)IBA 10/2019 - 03/2005
6	Retinaldehyde (Retinal)IBA 01/2019 - 06/2008
6	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2016 - 12/2009
5	Amyloid (Amyloid Fibrils)IBA 02/2024 - 12/2012
5	Cystatin CIBA 12/2023 - 08/2015
5	hydroxide ionIBA 12/2021 - 01/2014
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 05/2015
4	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2024 - 10/2015
4	Blood Proteins (Serum Proteins)IBA 11/2023 - 01/2018
4	Transcription Factors (Transcription Factor)IBA 10/2023 - 03/2006
4	Lipoprotein(a)IBA 11/2022 - 03/2008
4	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 02/2015
4	6-sulfatoxymelatoninIBA 01/2021 - 01/2015
4	Blood Glucose (Blood Sugar)IBA 01/2020 - 10/2005
4	AlbuminsIBA 11/2019 - 03/2016
4	25-hydroxyvitamin DIBA 04/2019 - 01/2014
4	Vitamin D FDA LinkGeneric 01/2018 - 01/2015
3	ElementsIBA 10/2023 - 03/2014
3	von Willebrand FactorIBA 01/2019 - 04/2004
3	AntibodiesIBA 01/2019 - 12/2005
3	Antihypertensive Agents (Antihypertensives)IBA 01/2018 - 03/2013
3	HDL LipoproteinsIBA 11/2013 - 06/2011
2	Docosahexaenoic AcidsIBA 01/2024 - 01/2021
2	Tyrosine (L-Tyrosine)FDA Link 10/2023 - 01/2018
2	Phospholipases (Phospholipase)IBA 10/2023 - 07/2019
2	Glial Fibrillary Acidic ProteinIBA 08/2023 - 10/2022
2	Peptides (Polypeptides)IBA 07/2023 - 12/2009
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 11/2013
2	ProteomeIBA 01/2021 - 01/2021
2	MelatoninIBA 01/2021 - 02/2015
2	Hormones (Hormone)IBA 01/2021 - 01/2012

Therapy/Procedure

8	Therapeutics 10/2023 - 02/2014
3	Replacement Arthroplasty 01/2016 - 06/2011
3	Hip Replacement Arthroplasty (Total Hip Replacement) 03/2013 - 08/2005
2	Traction 01/2021 - 08/2020